LBEL EFFET PARFAIT DUAL-USE COMPACT YOUTHFUL LOOKING SKIN SPF7

Product NDC: 13537-570
11-digit product format: 135370570
Labeler code: 13537
Product ID: 13537-570_a2aaa07b-d6c5-4f4a-9b5d-0d9c40ae91a5
Type: HUMAN OTC DRUG
Nonproprietary name: Titanium Dioxide
Dosage form: POWDER
Route: TOPICAL
Labeler: Ventura Corporation LTD.
Application: part352
Marketing category: OTC MONOGRAPH FINAL
Marketing start: 2013-09-16
Marketing end: 0000-00-00
Substance: TITANIUM DIOXIDE
Active strength: 0 g/g
NDC exclude flag: E
Listing certified through: 2017-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	13537-570		D	Discontinued by firm		2026-08-17
excluded package	package	13537-570	13537-570-01	D	Discontinued by firm		2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	13537-570-01	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	13537-570-01	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	13537-570-01	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	13537-570-01	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	13537-570-01	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	13537-570-01	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	13537-570-01	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	13537-570-01	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	13537-570-01	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	13537-570-01	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	13537-570-01	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	13537-570-01	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	13537-570-01	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	13537-570-01	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	13537-570-01	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	13537-570-01	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	13537-570-01	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	13537-570-01	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	13537-570-01	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	13537-570-01	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	13537-570-01	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		I	Inactivated by FDA	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	13537-570-01	I	Inactivated by FDA	`110d247fa046…`	`a55b01930146…`

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
13537-570-01	2025-05-19	C162847	48780-1	9855d018-e41d-cd31-e053-dbdaa90ab51a	L'BEL EFFET PARFAIT DUAL-USE COMPACT POWDER: YOUTHFUL LOOKING SKIN SPF7
13537-570-01	2019-11-27	C162847	48780-1	9855d018-e41d-cd31-e053-dbdaa90ab51a	L'BEL EFFET PARFAIT DUAL-USE COMPACT POWDER: YOUTHFUL LOOKING SKIN SPF7

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Titanium Dioxide	ACTIVE INGREDIENT	15FIX9V2JP	LBEL EFFET PARFAIT DUAL-USE COMPACT YOUTHFUL LOOKING SKIN SPF7 (TITANIUM DIOXIDE) POWDER [VENTURA CORPORATION LTD.]	1
Titanium Dioxide	ACTIVE MOIETY	15FIX9V2JP	LBEL EFFET PARFAIT DUAL-USE COMPACT YOUTHFUL LOOKING SKIN SPF7 (TITANIUM DIOXIDE) POWDER [VENTURA CORPORATION LTD.]	1
butylated hydroxytoluene	INACTIVE INGREDIENT	1P9D0Z171K	LBEL EFFET PARFAIT DUAL-USE COMPACT YOUTHFUL LOOKING SKIN SPF7 (TITANIUM DIOXIDE) POWDER [VENTURA CORPORATION LTD.]	1
calcium carbonate	INACTIVE INGREDIENT	H0G9379FGK	LBEL EFFET PARFAIT DUAL-USE COMPACT YOUTHFUL LOOKING SKIN SPF7 (TITANIUM DIOXIDE) POWDER [VENTURA CORPORATION LTD.]	1
dicaprylyl ether	INACTIVE INGREDIENT	77JZM5516Z	LBEL EFFET PARFAIT DUAL-USE COMPACT YOUTHFUL LOOKING SKIN SPF7 (TITANIUM DIOXIDE) POWDER [VENTURA CORPORATION LTD.]	1
dimethicone	INACTIVE INGREDIENT	92RU3N3Y1O	LBEL EFFET PARFAIT DUAL-USE COMPACT YOUTHFUL LOOKING SKIN SPF7 (TITANIUM DIOXIDE) POWDER [VENTURA CORPORATION LTD.]	1
ferric oxide red	INACTIVE INGREDIENT	1K09F3G675	LBEL EFFET PARFAIT DUAL-USE COMPACT YOUTHFUL LOOKING SKIN SPF7 (TITANIUM DIOXIDE) POWDER [VENTURA CORPORATION LTD.]	1
ferric oxide yellow	INACTIVE INGREDIENT	EX438O2MRT	LBEL EFFET PARFAIT DUAL-USE COMPACT YOUTHFUL LOOKING SKIN SPF7 (TITANIUM DIOXIDE) POWDER [VENTURA CORPORATION LTD.]	1
ferrosoferric oxide	INACTIVE INGREDIENT	XM0M87F357	LBEL EFFET PARFAIT DUAL-USE COMPACT YOUTHFUL LOOKING SKIN SPF7 (TITANIUM DIOXIDE) POWDER [VENTURA CORPORATION LTD.]	1
glycerin	INACTIVE INGREDIENT	PDC6A3C0OX	LBEL EFFET PARFAIT DUAL-USE COMPACT YOUTHFUL LOOKING SKIN SPF7 (TITANIUM DIOXIDE) POWDER [VENTURA CORPORATION LTD.]	1
high density polyethylene	INACTIVE INGREDIENT	UG00KM4WR7	LBEL EFFET PARFAIT DUAL-USE COMPACT YOUTHFUL LOOKING SKIN SPF7 (TITANIUM DIOXIDE) POWDER [VENTURA CORPORATION LTD.]	1
kaolin	INACTIVE INGREDIENT	24H4NWX5CO	LBEL EFFET PARFAIT DUAL-USE COMPACT YOUTHFUL LOOKING SKIN SPF7 (TITANIUM DIOXIDE) POWDER [VENTURA CORPORATION LTD.]	1
lauryl methacrylate/glycol dimethacrylate crosspolymer	INACTIVE INGREDIENT	EX0F4CZ66H	LBEL EFFET PARFAIT DUAL-USE COMPACT YOUTHFUL LOOKING SKIN SPF7 (TITANIUM DIOXIDE) POWDER [VENTURA CORPORATION LTD.]	1
magnesium myristate	INACTIVE INGREDIENT	Z1917F0578	LBEL EFFET PARFAIT DUAL-USE COMPACT YOUTHFUL LOOKING SKIN SPF7 (TITANIUM DIOXIDE) POWDER [VENTURA CORPORATION LTD.]	1
magnesium silicate	INACTIVE INGREDIENT	9B9691B2N9	LBEL EFFET PARFAIT DUAL-USE COMPACT YOUTHFUL LOOKING SKIN SPF7 (TITANIUM DIOXIDE) POWDER [VENTURA CORPORATION LTD.]	1
magnesium stearate	INACTIVE INGREDIENT	70097M6I30	LBEL EFFET PARFAIT DUAL-USE COMPACT YOUTHFUL LOOKING SKIN SPF7 (TITANIUM DIOXIDE) POWDER [VENTURA CORPORATION LTD.]	1
methylparaben	INACTIVE INGREDIENT	A2I8C7HI9T	LBEL EFFET PARFAIT DUAL-USE COMPACT YOUTHFUL LOOKING SKIN SPF7 (TITANIUM DIOXIDE) POWDER [VENTURA CORPORATION LTD.]	1
mica	INACTIVE INGREDIENT	V8A1AW0880	LBEL EFFET PARFAIT DUAL-USE COMPACT YOUTHFUL LOOKING SKIN SPF7 (TITANIUM DIOXIDE) POWDER [VENTURA CORPORATION LTD.]	1
octyldodecyl stearoyl stearate	INACTIVE INGREDIENT	3D47Q6D93C	LBEL EFFET PARFAIT DUAL-USE COMPACT YOUTHFUL LOOKING SKIN SPF7 (TITANIUM DIOXIDE) POWDER [VENTURA CORPORATION LTD.]	1
olive oil	INACTIVE INGREDIENT	6UYK2W1W1E	LBEL EFFET PARFAIT DUAL-USE COMPACT YOUTHFUL LOOKING SKIN SPF7 (TITANIUM DIOXIDE) POWDER [VENTURA CORPORATION LTD.]	1
pea	INACTIVE INGREDIENT	W4X7H8GYFM	LBEL EFFET PARFAIT DUAL-USE COMPACT YOUTHFUL LOOKING SKIN SPF7 (TITANIUM DIOXIDE) POWDER [VENTURA CORPORATION LTD.]	1
polyglyceryl-2 dipolyhydroxystearate	INACTIVE INGREDIENT	9229XJ4V12	LBEL EFFET PARFAIT DUAL-USE COMPACT YOUTHFUL LOOKING SKIN SPF7 (TITANIUM DIOXIDE) POWDER [VENTURA CORPORATION LTD.]	1
propylparaben	INACTIVE INGREDIENT	Z8IX2SC1OH	LBEL EFFET PARFAIT DUAL-USE COMPACT YOUTHFUL LOOKING SKIN SPF7 (TITANIUM DIOXIDE) POWDER [VENTURA CORPORATION LTD.]	1
silicon dioxide	INACTIVE INGREDIENT	ETJ7Z6XBU4	LBEL EFFET PARFAIT DUAL-USE COMPACT YOUTHFUL LOOKING SKIN SPF7 (TITANIUM DIOXIDE) POWDER [VENTURA CORPORATION LTD.]	1
talc	INACTIVE INGREDIENT	7SEV7J4R1U	LBEL EFFET PARFAIT DUAL-USE COMPACT YOUTHFUL LOOKING SKIN SPF7 (TITANIUM DIOXIDE) POWDER [VENTURA CORPORATION LTD.]	1
water	INACTIVE INGREDIENT	059QF0KO0R	LBEL EFFET PARFAIT DUAL-USE COMPACT YOUTHFUL LOOKING SKIN SPF7 (TITANIUM DIOXIDE) POWDER [VENTURA CORPORATION LTD.]	1
xanthan gum	INACTIVE INGREDIENT	TTV12P4NEE	LBEL EFFET PARFAIT DUAL-USE COMPACT YOUTHFUL LOOKING SKIN SPF7 (TITANIUM DIOXIDE) POWDER [VENTURA CORPORATION LTD.]	1
zinc stearate	INACTIVE INGREDIENT	H92E6QA4FV	LBEL EFFET PARFAIT DUAL-USE COMPACT YOUTHFUL LOOKING SKIN SPF7 (TITANIUM DIOXIDE) POWDER [VENTURA CORPORATION LTD.]	1

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
15FIX9V2JP	TITANIUM DIOXIDE	13463-67-7	TITANIUM DIOXIDE

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
L'BEL EFFET PARFAIT DUAL-USE COMPACT POWDER: YOUTHFUL LOOKING SKIN SPF7	Ventura Corporation LTD. \| Bel Star S.A. (Colombia)	2013-09-13	HUMAN OTC DRUG LABEL	1

LBEL EFFET PARFAIT DUAL-USE COMPACT YOUTHFUL LOOKING SKIN SPF7

NDC auxiliary status#

Observed NDC auxiliary status history#

FDA-Initiated Inactive NDC Indexing#

DailyMed Socrata Ingredients#

Related Records#

Related UNII Ingredients#

Related DailyMed Labels#